Insider · CIK 0002061924
Craig Tendler
Files at HURA (Kintara Therapeutics, Inc.), PBLS (Parabilis Medicines, Inc.). First filing -, latest -.
In brief
Craig Tendler files SEC Form 4 as director at HURA (Kintara Therapeutics, Inc.), and also at PBLS (Parabilis Medicines, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Craig Tendler has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 2 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 22, 2026 | PBLS Parabilis Medicines, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +20,294 | $0.00 | $0 | 20,294 | Aug 25, 2026 |
| Feb 12, 2026 | HURA Kintara Therapeutics, Inc. | AGrant or award Options (Right to Buy)derivative | +156,240 | $0.00 | $0 | 156,240 | Feb 17, 2026 |
Questions about Craig Tendler
Answered from the filings on this page, as of the latest one.
Is Craig Tendler buying or selling?
Craig Tendler has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Craig Tendler's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Craig Tendler has 0.
Where does Craig Tendler file Form 4?
Craig Tendler has filed Form 4 at HURA (Kintara Therapeutics, Inc.); PBLS (Parabilis Medicines, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.